FDA’s Draft Guidance on Externally Controlled Trials Answers Some Questions, Leaves Others Unanswered
FDA Law Blog
APRIL 23, 2023
This Draft Guidance focuses on the use of patient-level data from other clinical trials or from RWD sources. The goal is to select similar patients in the treatment and external control groups.
Let's personalize your content